High Bcl-xL/Bcl-xS mRNA ratios, associated with greater tumor cell survival, can be found in a number of cancer types, including human lymphoma, breast cancer, prostate cancer and human hepatocellular carcinoma [33,34,35,36]. Here, BCL2L1 is linked to breast cancer.